Innovative Collaborative R&D: Fusing Aseptic Processing and Gene & Cell Therapy for Advanced Biopharmaceuticals
Event Timeslots (1)
Day 2 – Fri, February 23rd, 2024
-
Section 5: Driving Synergies Between APT and GCT
GENAP Summit is a brand owned by EPM Group, registered company in Portugal. EU VAT ID PT513501312